Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,371.20
+10.40 (0.76%)
At close: Nov 6, 2026
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,527 employees as of March 31, 2026. The number of employees decreased by 284 or 1.02% compared to the previous year. That makes Dr. Reddy's Laboratories the 1,364th largest employer in the world and 81st in India.
Employees
27,527
Change (1Y)
-284
Growth (1Y)
-1.02%
Revenue / Employee
11.98M INR
Profits / Employee
1.02M INR
Market Cap
1.14T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 27,527 | -284 | -1.02% |
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lupin | 26,021 |
| Torrent Pharmaceuticals | 18,258 |
| Jubilant Pharmova | 5,657 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Granules India | 4,306 |
| Caplin Point Laboratories | 4,199 |
| Abbott India | 3,679 |
| GlaxoSmithKline Pharmaceuticals | 3,103 |
Dr. Reddy's Laboratories News
- 1 day ago - Dr.Reddy's Wins Brazil Approval For Generic Ozempic Alternative - Nasdaq
- 2 days ago - Indian drugmaker Dr Reddy's gets Brazil regulator nod to sell generic Ozempic - Reuters
- 3 days ago - Reddy's Gets Tentative FDA Nod For Twice-Yearly HIV Prevention Shot At $40 A Year - Nasdaq
- 4 days ago - Dr Reddy's gets tentative US FDA nod for generic HIV prevention - Reuters
- 4 days ago - Dr Reddy’s gets USFDA nod for first generic twice-yearly injectable HIV prevention drug Lenacapavir - The Times of India
- 8 days ago - Dr. Reddy's Laboratories Limited Announces USFDA Classifies FTO-SEZ Process Unit-02 Inspection as Voluntary Action Indicated - Nasdaq
- 12 days ago - Dr. Reddy’s upgraded to Hold from Underperform at Jefferies - TheFly
- 12 days ago - Dr. Reddy’s upgraded to Neutral from Underweight at JPMorgan - TheFly